These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9619341)

  • 1. New approaches to insulin resistance in polycystic ovarian syndrome.
    Davison RM
    Curr Opin Obstet Gynecol; 1998 Jun; 10(3):193-8. PubMed ID: 9619341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance in polycystic ovary syndrome.
    Prelevic GM
    Curr Opin Obstet Gynecol; 1997 Jun; 9(3):193-201. PubMed ID: 9263704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-Mediated Diseases: Adrenal Mass and Polycystic Ovary Syndrome.
    Muscogiuri G; Colao A; Orio F
    Trends Endocrinol Metab; 2015 Oct; 26(10):512-514. PubMed ID: 26412152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of genetic and environmental factors in the development of polycystic ovary syndrome].
    Ságodi L; Kiss-Tóth E; Barkai L
    Orv Hetil; 2013 Apr; 154(17):650-7. PubMed ID: 23608312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polycystic ovary syndrome of extra-ovarian origin. Review].
    Terán Dávila J; Teppa-Garrán AD
    Invest Clin; 2001 Mar; 42(1):51-78. PubMed ID: 11294032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin and polycystic ovary syndrome.
    Lebinger TG
    Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):132-40. PubMed ID: 17940431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of obesity and adiposity in polycystic ovary syndrome.
    Diamanti-Kandarakis E
    Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of insulin and hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome].
    Vasiljević M
    Srp Arh Celok Lek; 2000; 128(9-10):335-9. PubMed ID: 11255689
    [No Abstract]   [Full Text] [Related]  

  • 9. [Insulin resistance and polycystic ovary syndrome].
    Dewailly D; Cortet-Rudelli C; Nobels F; Henric B; Longelin C; Fossati P
    Ann Endocrinol (Paris); 1992; 53(1):1-7. PubMed ID: 1444176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperinsulinism and insulin resistance diagnosed by oral and intravenous glucose loading and by the tolbutamide test in polycystic ovary syndrome].
    Cotrozzi G; Matteini M; Relli P; Lazzari T
    Recenti Prog Med; 1983 Mar; 74(3):289-97. PubMed ID: 6612073
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin resistance and the long-term consequences of polycystic ovary syndrome.
    Bhathena RK
    J Obstet Gynaecol; 2011; 31(2):105-10. PubMed ID: 21281021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hyperinsulinaemia in polycystic ovary syndrome?
    van Montfrans JM; van Hooff MH; Hompes PG; Lambalk CB
    Hum Reprod; 1998 Jan; 13(1):5-6. PubMed ID: 9512218
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome.
    Poretsky L; Piper B
    Obstet Gynecol; 1994 Oct; 84(4):613-21. PubMed ID: 8090402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should patients with polycystic ovarian syndrome be treated with metformin? A note of cautious optimism.
    Homburg R
    Hum Reprod; 2002 Apr; 17(4):853-6. PubMed ID: 11925372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovaries and obesity.
    Messinis IE; Messini CI; Anifandis G; Dafopoulos K
    Best Pract Res Clin Obstet Gynaecol; 2015 May; 29(4):479-88. PubMed ID: 25487256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
    Unlühizarci K; Keleştimur F; Bayram F; Sahin Y; Tutuş A
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):231-6. PubMed ID: 10468995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of polycystic ovary syndrome: what is the role of obesity?
    Salehi M; Bravo-Vera R; Sheikh A; Gouller A; Poretsky L
    Metabolism; 2004 Mar; 53(3):358-76. PubMed ID: 15015150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin resistance and hyperinsulinemia in pathogenesis of polycystic ovary syndrome].
    Majkowska L
    Endokrynol Pol; 1993; 44(4):589-600. PubMed ID: 8055826
    [No Abstract]   [Full Text] [Related]  

  • 19. [Polycystic ovarian disease. 1. The current data on its etiology and pathogenesis].
    Rachev E
    Akush Ginekol (Sofiia); 1999; 38(2):42-5. PubMed ID: 10730388
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion.
    Geffner ME; Kaplan SA; Bersch N; Golde DW; Landaw EM; Chang RJ
    Fertil Steril; 1986 Mar; 45(3):327-33. PubMed ID: 3512314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.